dimethylacetamide has been researched along with busulfan in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, BS; Bhagwatwar, HP; Chow, DS; Phadungpojna, S | 1 |
| Andersson, BS; Blume, KG; Champlin, RE; Chow, DS; Hu, WW; Madden, T; Tran, HT; Vaughan, WP | 1 |
| Boos, J; Hempel, G; Oechtering, D | 1 |
| Boos, J; Gruhn, B; Hempel, G; Klingebiel, T; Lanvers-Kaminsky, C; Oechtering, D; Vormoor, J | 1 |
| Bartelink, IH; Boelens, JJ; Boos, J; Hempel, G; Trame, MN | 1 |
| Bartelink, I; Boelens, J; Boos, J; Diestelhorst, C; Hempel, G; Kerl, K; Trame, MN | 1 |
| Belda-Furió, M; Borrell-García, C; Cueto-Sola, M; Escobar-Cava, P; López-Briz, E; Poveda-Andrés, JL | 1 |
| Byrne, JA; Cendana, M; Earl, J; Lee, S; Nath, CE; Shaw, PJ; Upadhyay, PJ | 1 |
| Chung, J; Hempel, G; Keogh, SJ; McLachlan, AJ; Nath, CE; Rosser, SPA; Shaw, PJ | 1 |
| Andersson, BS; Chan, KH; Nieto, Y; Ramdial, J; Sanchez Petitto, G; Valdez, B | 1 |
1 trial(s) available for dimethylacetamide and busulfan
| Article | Year |
|---|---|
Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study.
Topics: Acetamides; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biological Availability; Busulfan; Cyclophosphamide; Drug Carriers; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Intestinal Absorption; Male; Middle Aged; Polyethylene Glycols; Safety; Solvents; Transplantation Conditioning | 2000 |
9 other study(ies) available for dimethylacetamide and busulfan
| Article | Year |
|---|---|
Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy.
Topics: Acetamides; Animals; Antineoplastic Agents, Alkylating; Busulfan; Cell Survival; Chemistry, Pharmaceutical; Drug Stability; Hemolysis; HL-60 Cells; Humans; Injections, Intravenous; Kinetics; Male; Osmolar Concentration; Polyethylene Glycols; Rats; Solubility; Solvents; Water | 1996 |
Monitoring of N,N-dimethylacetamide in children during i.v.-busulfan therapy by liquid chromatography-mass spectrometry.
Topics: Acetamides; Adolescent; Busulfan; Child; Child, Preschool; Chromatography, Liquid; Humans; Infant; Infusions, Intravenous; Mass Spectrometry; Reference Standards; Reproducibility of Results; Solvents | 2006 |
Cytotoxicity of dimethylacetamide and pharmacokinetics in children receiving intravenous busulfan.
Topics: Acetamides; Adolescent; Antineoplastic Agents, Alkylating; Busulfan; Cell Line, Tumor; Child; Child, Preschool; Cryoprotective Agents; Dose-Response Relationship, Drug; Humans; Infant; Infusions, Intravenous | 2007 |
Population pharmacokinetics of dimethylacetamide in children during standard and once-daily IV busulfan administration.
Topics: Acetamides; Adolescent; Busulfan; Child; Child, Preschool; Drug Administration Schedule; Drug Monitoring; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Metabolic Clearance Rate; Models, Biological; Myeloablative Agonists; Pharmaceutical Vehicles | 2013 |
Evaluation of effects of busulfan and DMA on SOS in pediatric stem cell recipients.
Topics: Acetamides; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cryoprotective Agents; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Male; Prognosis; Retrospective Studies; Risk Factors; Transplantation, Homologous; Young Adult | 2014 |
Incompatibility of undiluted busulfan injection with a needle-free valve.
Topics: Acetamides; Busulfan; Drug Incompatibility; Humans; Infusions, Intravenous; Silicones; Solvents | 2014 |
An HPLC-UV method for determining plasma dimethylacetamide concentrations in patients receiving intravenous busulfan.
Topics: Acetamides; Alkylating Agents; Busulfan; Chromatography, High Pressure Liquid; Humans; Infusions, Intravenous; Reference Standards; Spectrophotometry, Ultraviolet | 2017 |
Validation of a liquid chromatography-tandem mass spectrometry method for simultaneous quantification of N,N-dimethylacetamide and N-monomethylacetamide in pediatric plasma.
Topics: Busulfan; Child; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Methanol; Tandem Mass Spectrometry | 2023 |
Intravenous Busulfan, Dimethylacetamide and neurotoxicity after high-dose pretransplant conditioning chemotherapy.
Topics: Acetamides; Administration, Intravenous; Busulfan; Hematopoietic Stem Cell Transplantation; Humans; Myeloablative Agonists; Transplantation Conditioning | 2023 |